Stereoselective capture of n-acyliminium ions generated from a-hydroxy-n-acylcarbamides: Direct synthesis of uracils from barbituric acids enabled by smi2 reduction

Organic Letters

Volumn 16, Issue 2, 2014, Pages 452-455

  Szostak, Michal ^a   Sautier, Brice ^a   Procter, David J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINOALCOHOL; BARBITURIC ACID; BARBITURIC ACID DERIVATIVE; DRUG DERIVATIVE; IMINE; ION; LEWIS ACID; URACIL;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

AMINO ACIDS; AMINO ALCOHOLS; BARBITURATES; CATALYSIS; COMBINATORIAL CHEMISTRY TECHNIQUES; IMINES; IONS; LEWIS ACIDS; MOLECULAR STRUCTURE; STEREOISOMERISM; URACIL;

EID: 84896693030     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol403340j     Document Type: Article

References (44)

1. (a) Brunton, L.; Chabner, B.; Knollman, B. Goodman and Gilman's The Pharmacological Basis of Therapeutics; McGraw-Hill: New York, 2010
2. Bloomfield, V. A.; Crothers, D. M.; Tinoco, I. Nucleic Acids: Structures, Properties and Functions; University Science Books: Sausalito, CA, 2000.
3. Selected examples: (a) Hopkins, A. L.; Ren, J.; Tanaka, H.; Baba, M.; Okamato, M.; Stuart, D. I.; Stammers, D. K. J. Med. Chem. 1999, 42, 4500
4. Klein, R. S.; Lenzi, M.; Lim, T. H.; Hotchkiss, K. A.; Wilson, P.; Schwartz, E. L. Biochem. Pharmacol. 2001, 62, 1257
5. Fustero, S.; Salavert, E.; Sanz-Cervera, J. F.; Piera, J.; Asensio, A. Chem. Commun. 2003, 844
6. Kalman, T. I.; Lai, L. Nucleosides, Nucleotides Nucleic Acids 2005, 24, 367
7. LaFrate, A. L.; Katzenellenbogen, J. A. J. Org. Chem. 2007, 72, 8573
8. Novikov, M. S.; Ivanova, O. N.; Ivanov, A. V.; Ozerov, A. A.; Valuev-Elliston, V. T.; Temburnikar, K.; Gurskaya, G. V.; Kochetkov, S. N.; Pannecouque, C.; Balzarini, J.; Seley-Radtke, K. L. Bioorg. Med. Chem. Lett. 2011, 19, 5794
9. Liu, Y.; Lim, B. H.; Jiang, W. W.; Flentge, C. A.; Hutchinson, D. K.; Madigan, D. L.; Randolph, J. T.; Wagner, R.; Maring, C. J.; Kati, W. M.; Molla, A. Bioorg. Med. Chem. Lett. 2012, 22, 3747.
10. (a) Bardagi, J. I.; Rossi, R. A. Org. Prep. Proc. Int. 2009, 41, 479.
11. (b) Joule, J. A.; Mills, K. Heterocyclic Chemistry; Wiley-Blackwell: Oxford, 2010.
12. Reviews: (a) Bojarski, J. T.; Mokrosz, J. L.; Barton, H. J.; Paluchowska, M. H. Adv. Heterocycl. Chem. 1985, 38, 229
13. Abraham, D. J.; Rotella, D. P. Burger's Medicinal Chemistry, Drug Discovery and Development; Wiley: Hoboken, NJ, 2010
14. Seeliger, F.; Berger, S. T. A.; Remennikov, G. Y.; Polborn, K.; Mayr, H. J. Org. Chem. 2007, 72, 9170.
15. Reviews: (a) Speckamp, W. N.; Moolenaar, M. J. Tetrahedron 2000, 56, 3817
16. Maryanoff, B. E.; Zhang, H. C.; Cohen, J. H.; Turchi, I. J.; Maryanoff, C. A. Chem. Rev. 2004, 104, 1431
17. Yazici, A.; Pyne, S. G. Synthesis 2009, 339
18. Yazici, A.; Pyne, S. G. Synthesis 2009, 513.
19. Selected examples: (a) Roper, S.; Wartchow, R.; Hoffmann, H. M. R. Org. Lett. 2002, 4, 3179
20. Muratore, M. E.; Holloway, C. A.; Pilling, A. W.; Storer, R. I.; Trevitt, G.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 10796
21. Breman, A. C.; Dijkink, J.; van Maarseveen, J. H.; Kinderman, S. S.; Hiemstra, H. J. Org. Chem. 2009, 74, 6327
22. Mentink, G.; van Maarseveen, J. H.; Hiemstra, H. Org. Lett. 2002, 4, 3497
23. Sun, H.; Martin, C.; Kesselring, D.; Keller, R.; Moeller, K. D. J. Am. Chem. Soc. 2006, 128, 13761
24. Raheem, I. T.; Thiara, P. S.; Peterson, E. A.; Jacobsen, E. N. J. Am. Chem. Soc. 2007, 129, 13404.
25. (a) Szostak, M.; Sautier, B.; Spain, M.; Behlendorf, M.; Procter, D. J. Angew. Chem., Int. Ed. 2013, 52, 12559
26. α-Hydroxy-Nacylcarbamides were prepared using SmI2-H2O (dr 77:23 to 91:9). The stereochemistry at the hemiaminal center has no bearing on the stereochemical outcome of the additions.
27. Reviews on SmI2: (a) Kagan, H. B. Tetrahedron 2003, 59, 10351.
28. (b) Molander, G. A.; Harris, C. R. Tetrahedron 1998, 54, 3321.
29. (c) Edmonds, D. J.; Johnston, D.; Procter, D. J. Chem. Rev. 2004, 104, 3371
30. Nicolaou, K. C.; Ellery, S. P.; Chen, J. S. Angew. Chem., Int. Ed. 2009, 48, 7140
31. Szostak, M.; Procter, D. J. Angew. Chem., Int. Ed. 2011, 50, 7737
32. Szostak, M.; Spain, M.; Procter, D. J. Chem. Soc. Rev. 2013, 42, 9155.
33. Recent applications of SmI2-H2O: (a) Szostak, M.; Spain, M.; Procter, D. J. Chem. Commun. 2011, 47, 10254
34. Szostak, M.; Spain, M.; Procter, D. J. Org. Lett. 2012, 14, 840.
35. Deuterated drugs: (a) Katsnelson, A. Nat. Med 2013, 19, 656.
36. Deuterated uracil derivatives: (b) Srinivas, G.; Unny, V. K. P.; Mukkanti, K.; Choudary, B. M. Appl. Radiat. Isot. 2013, 72, 100.
37. Deuteration using SmI2-D2O: (c) Concellon, J. M.; Bernad, P. L.; Rodríguez-Solla, H. Angew. Chem., Int. Ed. 2001, 40, 3897
38. Davies, S. G.; Rodríguez-Solla, H.; Tamayo, J. A.; Garner, A. C.; Smith, A. D. Chem. Commun. 2004, 2502.
39. For a related 1,2-shift, see: (a) Nguyen, Q.; Nguyen, T.; Driver, T. G. J. Am. Chem. Soc. 2013, 135, 620.
40. Activation of Sm(II): (b) Szostak, M.; Procter, D. J. Angew. Chem., Int. Ed. 2012, 51, 9238.
41. (a) Burke, M. D.; Schreiber, S. L. Angew. Chem., Int. Ed. 2004, 43, 46
42. Galloway, W. R. J. D.; Isidro-Llobet, A.; Spring, D. R. Nat. Commun. 2010, 1, no. 80
43. O'Connor, C. J.; Beckmann, H. S. G.; Spring, D. R. Chem. Soc. Rev. 2012, 41, 4444.
44. Szostak, M.; Sautier, B.; Procter, D. J. Chem. Commun. 2013, DOI: 10.1039/C3CC48932A.